In a significant move to bolster pandemic preparedness, the United States government has committed $176 million to vaccine manufacturer Moderna for the development of a new mRNA vaccine aimed at combating bird flu. This effort comes as the H5N1 virus, commonly known as bird flu, continues to make its presence felt in dairy herds across multiple states.
The U.S. Department of Health and Human Services (HHS) will provide the funds, emphasizing the potential of mRNA technology, which has proven effective in the rapid development of COVID-19 vaccines. This initiative is a proactive step to ensure readiness against a possible bird flu pandemic, leveraging the same technological advancements that facilitated the swift response to the coronavirus outbreak.
Conquer the Wild with More Power, Less Hassle – Survival Made Easy!
Federal officials announced this funding arrangement on Tuesday, underlining the critical need for continued innovation in vaccine development. The award comes through the Biomedical Advanced Research and Development Authority (BARDA), a program dedicated to fostering medical treatments for emerging pandemic threats. Moderna is set to use these funds to advance trials that will test the safety and effectiveness of this new mRNA-based vaccine.
>> Click Here To Continue Reading <<
